Promius DFD-06-CD-011

Mar 3, 2021

Started: 5/2017

Study Name: An Open Label, Multicenter Study to Assess the Potential for Adrenal Suppression and Systemic Drug Absorption Following Multiple Dosing with XXX(0.025%) in Pediatric Subjects with Moderate to Severe Plaque Psoriasis”

Indication: Psoriasis

Principal Investigator: Sahra Niazi

This study is no longer active

Current Studies